Literature DB >> 10477607

Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.

A E Lukacher1, J M Moser, A Hadley, J D Altman.   

Abstract

T cells are critical for clearing infection and preventing tumors induced by polyoma virus, a natural murine papovavirus. We previously identified the immunodominant epitope for polyoma virus-specific CTL in tumor-resistant H-2k mice as the Dk-restricted peptide, MT389-397, derived from the polyoma middle T oncoprotein. In this study, we developed tetrameric Dk complexes containing the MT389-397 peptide to directly visualize and enumerate MT389-397-specific CTL during polyoma virus infection. We found that Dk/MT389 tetramer+CD8+ T cells undergo a massive expansion during primary infection such that by day 7 postinfection these Ag-specific CD8+ T cells constitute approximately 20% of the total and approximately 40% of the activated CD8+ T cells in the spleen. This expansion of Dk/MT389 tetramer+CD8+ T cells parallels the emergence of MT389-397-specific ex vivo cytolytic activity and clearance of polyoma virus. Notably, Dk/MT389 tetramer+CD8+ T cells are maintained in memory at very high levels. The frequencies of Dk/MT389 tetramer+CD8+ effector and memory T cells in vivo match those of CD8+ T cells producing intracellular IFN-gamma after 6-h in vitro stimulation by MT389-397 peptide. Consistent with preferential Vbeta6 expression by MT389-397-specific CD8+CTL lines and clones, Dk/MT389 tetramer+CD8+ T cells exhibit biased expression of this Vbeta gene segment. Finally, we show that Dk/MT389 tetramer+CD8+ T cells efficiently infiltrate a polyoma tumor challenge to virus-immune mice. Taken together, these findings strongly implicate virus-induced MT389-397-specific CD8+ T cells as essential effectors in eliminating polyoma-infected and polyoma-transformed cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477607

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Induction of polyomavirus-specific CD8(+) T lymphocytes by distinct dendritic cell subpopulations.

Authors:  D R Drake; M L Shawver; A Hadley; E Butz; C Maliszewski; A E Lukacher
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells.

Authors:  Qingsong Qin; Matthew Lauver; Saumya Maru; Eugene Lin; Aron E Lukacher
Journal:  Virology       Date:  2017-01-05       Impact factor: 3.616

3.  Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.

Authors:  Qingsong Qin; Elizabeth L Frost; Saumya Maru; Aron E Lukacher
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

4.  Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection.

Authors:  Vitaly V Ganusov; Aron E Lukacher; Anthony M Byers
Journal:  Virology       Date:  2010-06-26       Impact factor: 3.616

5.  Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.

Authors:  Palanivel Velupillai; John P Carroll; Thomas L Benjamin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.

Authors:  Rabinarayan Mishra; Alex T Chen; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

7.  Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection.

Authors:  Christopher S Sullivan; Chang K Sung; Christopher D Pack; Adam Grundhoff; Aron E Lukacher; Thomas L Benjamin; Don Ganem
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

8.  Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Authors:  Rabinarayan Mishra; Bojan Polic; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

9.  Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Authors:  Christopher C Kemball; Eva Szomolanyi-Tsuda; Aron E Lukacher
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.

Authors:  Sadna Budhu; John D Loike; Ashley Pandolfi; Soo Han; Geoffrey Catalano; Andrei Constantinescu; Raphael Clynes; Samuel C Silverstein
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.